JupiteX Get the app
Health & Medicine16 Nov 2026 · about 7 min

Shanghai fires 2 scientists after girl dies in world's first brain gene-editing attempt

The brief

Investigators identified failures in safety reporting, clinical review and disclosure of financial conflicts. These safeguards matter because they help protect patients and make research findings trustworthy. The investigation found no fabricated data in the published paper, but it did identify academic irregularities, including differences between the methods used and those described. Qiu Zilong’s team did not promptly tell the hospital’s clinical study leader about a February 2025 safety report on nonhuman primates. The warning signals were therefore not heeded before the girl’s March injection. Investigators also faulted the team’s disclosure of the safety report and the girl’s death in connection with its Nature paper. None of four team members accurately disclosed conflicts of interest. Shanghai dismissed Qiu and Yang Kan and barred both from state science and technology programs and awards for five years. They were also entered into a database of serious research integrity violations. Other team members received administrative warnings, while hospital officials and institutions faced separate penalties. The case also prompted special inspections of clinical research involving new biomedical technologies.

01

What failures did investigators identify that led to the researchers’ dismissals and research bans?

Investigators identified failures in safety reporting, clinical review and disclosure of financial conflicts. These safeguards matter because they help protect patients and make research findings trustworthy. The investigation found no fabricated data in the published paper, but it did identify academic irregularities, including differences between the methods used and those described.

Qiu Zilong’s team did not promptly tell the hospital’s clinical study leader about a February 2025 safety report on nonhuman primates. The warning signals were therefore not heeded before the girl’s March injection. Investigators also faulted the team’s disclosure of the safety report and the girl’s death in connection with its Nature paper. None of four team members accurately disclosed conflicts of interest.

Shanghai dismissed Qiu and Yang Kan and barred both from state science and technology programs and awards for five years. They were also entered into a database of serious research integrity violations. Other team members received administrative warnings, while hospital officials and institutions faced separate penalties. The case also prompted special inspections of clinical research involving new biomedical technologies.

02

What happened after the girl received the experimental injection, and what complication did reviewers identify as the cause of her death?

The girl received an experimental gene-editing injection at Xinhua Hospital on March 24, 2025. She died on March 31, despite efforts to resuscitate her. Her death brought the risks of this first-of-its-kind treatment into sharp focus: she had a rare disorder with no effective treatment, and the therapy was designed to target the central nervous system.

At an emergency review on April 2, the hospital ethics committee concluded that she had died of thrombotic microangiopathy. The committee identified it as a complication of the gene therapy and ordered the study stopped. Thrombotic microangiopathy is a serious condition involving damage to small blood vessels; the article does not provide further clinical details about her individual case.

Investigators later found that the research team had not promptly shared a safety report on nonhuman primates with the hospital’s clinical study leader. That report had been completed in February, the month before the injection. The case also led to sanctions for researchers and hospital officials, as well as special inspections of clinical research involving new biomedical technologies.

03

How much money did the family contribute to the research, and how much money and gifts did researchers receive personally?

The family’s contribution to the research was 5.337 million yuan, reported as about US$800,000. Separately, researchers received about 1.06 million yuan, or $159,000, in money and gifts from the family. The figures describe two different flows of money: research funding and personal benefits to researchers.

Most of the family’s research contribution paid for viral vectors made by a Guangzhou company and large-animal safety tests conducted by another company in Sichuan. Yang Kan received 900,000 yuan and premium liquor. Qiu Zilong received premium liquor and electronics valued at about 100,000 yuan. Two other team members, surnamed Zhang and Yuan, each received 30,000 yuan.

Investigators found that none of the four accurately disclosed conflicts of interest in the research paper. The investigation statement said the money and gifts had all been returned or handed over. The case led to dismissals, research bans and other penalties, alongside new city inspections of clinical research involving emerging biomedical technologies.

04

What is thrombotic microangiopathy, the serious complication identified in the emergency review?

Thrombotic microangiopathy, often shortened to TMA, is a group of serious conditions in which small blood vessels become damaged and tiny clots form. In general medical knowledge, this can disrupt blood flow and injure organs. The article does not describe the girl’s specific symptoms or the exact biological process in her case.

At an emergency review on April 2, the hospital ethics committee concluded that the girl had died of TMA and identified it as a complication of the gene therapy. She had received the injection on March 24 and died on March 31 despite resuscitation efforts. The committee ordered the study stopped after its review.

The finding is important because it identifies a serious harm associated with the experimental treatment, but it does not by itself explain every step that caused the complication. Investigators separately found that a safety report on nonhuman primates had not been promptly shared with the hospital’s clinical study leader. The article reports that the study was stopped and the researchers faced sanctions.

05

How can viral vectors carry gene-editing tools into cells in the central nervous system?

In general, a viral vector is a modified virus used to carry genetic material into cells. Researchers can design vectors to deliver a selected payload rather than cause the illness associated with a natural virus. The article does not identify the vector’s design or explain how it entered individual cells, so those details cannot be established from this report.

The article says this therapy used viruses carrying the editor and delivered them by infusing them into the girl’s spinal fluid. It describes the treatment as directed at the brain and intended to address a disorder affecting the central nervous system. The reported route placed the vector-containing fluid into the spinal canal, but the article does not give technical details about distribution or cell uptake.

The girl received the injection at Xinhua Hospital on March 24, 2025, and died a week later. An emergency review identified thrombotic microangiopathy as a gene-therapy complication and stopped the study. Investigators also found that a nonhuman-primate safety report had not been promptly shared with the hospital’s clinical study leader before treatment.

06

Why are animal safety tests and independent ethics review important before an experimental therapy is given to a person?

Animal safety tests and independent ethics review are safeguards before experimental treatments reach people. In general, animal studies can help identify possible harms, while an ethics committee can assess whether the evidence and consent process justify exposing a participant to risk. These checks cannot guarantee safety, but they can reveal concerns that need attention before a trial proceeds.

Here, investigators found that Qiu’s team did not promptly tell the hospital’s clinical study leader about a safety report on nonhuman primates. It had been completed in February 2025, the month before the girl’s injection. Investigators also found that the ethics committee approved the study despite insufficient toxicology and safety evidence, although additional material it had requested had not been supplied.

The committee’s consent form mentioned possible serious complications but did not prominently warn the family that the girl could die. After her death, the committee identified thrombotic microangiopathy as a complication and ordered the study stopped. The case led to penalties and to special inspections of clinical research involving new biomedical technologies in Shanghai.

07

What does gene editing do to DNA, and how might changing DNA help treat a genetic disorder?

Gene editing is a way of making targeted changes to DNA, the molecule that carries genetic instructions in cells. Depending on the tool and the goal, an edit can alter a DNA sequence. This is general scientific background; the article does not explain which DNA change the researchers intended to make in this treatment.

A genetic disorder can result from a DNA change that disrupts how a gene works. In principle, editing that sequence could help restore or alter the gene’s function. The girl had Snijders Blok-Campeau syndrome, a rare neurodevelopmental disorder with no effective treatment. Her family sought a customized therapy intended to target the central nervous system, and the viruses carrying the editor were infused into her spinal fluid.

The article does not report the precise genetic target or say whether the intended DNA change worked. The girl received the injection on March 24, 2025, and died on March 31. An emergency review identified thrombotic microangiopathy as a gene-therapy complication and ordered the study stopped. Investigators later found failures in safety reporting, clinical review and disclosure of financial conflicts.

This brief was written by AI from the original reporting and checked by other models. Names, figures and quotes come from the source; read it for full context.

Read more in the JupiteX app

Pulse is free. New stories every 4 hours, each one broken into the questions that explain it.

Or read more news on the web